期刊档案 · HEMATOLOGYPATHOLOGY-PATHOLOGY
Journal of Hematopathology
ISSN 1868-9256 · eISSN 1865-5785 · Springer Berlin Heidelberg · NETHERLANDS · 4 issues per year · 创刊 2008
Journal of Hematopathology 中科院 医学 4区（2025 年升级版），影响因子 1.03，混合开放获取，APC 约 3,890 美元，近 24 个月 77 篇文章投稿到接收中位 74 天，2025 年发文 61 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Journal of Hematopathology 由 Springer Berlin Heidelberg 出版，属中科院医学大类（2025 升级版4区）。按 OpenAlex 近年发文统计，该刊主要发表 Lymphoma Diagnosis and Treatment、Chronic Lymphocytic Leukemia Research、Viral-associated cancers and disorders 等主题的论文，这 3 个主题约占 42.9%。（根据 OpenAlex 主题统计与中科院分区数据生成）
The Journal of Hematopathology aims at providing pathologists with a special interest in hematopathology with information needed to perform high-quality diagnostic pathology of hematopoietic and lymphoid diseases in lymphoid tissues, bone marrow and peripheral blood. To this end the journal publishes reviews, editorials, comments, original papers, guidelines and protocols, papers on ancillary techniques, case reports, and images on all topics within the subspecialty of diagnostic hematopathology. The journal is a useful reference point for all pathologists with an interest in hematopathology. Molecular biologists involved in the expanding field of molecular diagnostics and research on lymphomas and leukemia benefit from the journal, too. Furthermore, the journal is of major interest for hematologists dealing with patients suffering from lymphomas, leukemias, and other benign and malignant hematopoietic and lymphoid diseases. The journal maintains an international character among its editors, editorial board and authorship, as the field of hematopathology has considerable geographical variations in incidence of diseases. This is not only locally relevant, but due to globalization, relevant for all those involved in the management of patients with hematolymphoid patients.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：HEMATOLOGYPATHOLOGY-PATHOLOGY
主编 Nathanael G. Bailey出版商官网
编委会国家分布：未见中国大陆编委；主要国家 美国 23、德国 5、荷兰 2、瑞士 2、中国香港 1（共 41 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Lymphoma Diagnosis and TreatmentMedicine20.6%
- Chronic Lymphocytic Leukemia ResearchMedicine11.9%
- Viral-associated cancers and disordersMedicine10.5%
- Acute Myeloid Leukemia ResearchMedicine9.3%
- Hematological disorders and diagnosticsMedicine4.3%
- Chronic Myeloid Leukemia TreatmentsMedicine4%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine4%
- CNS Lymphoma Diagnosis and TreatmentMedicine3.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 病理学PATHOLOGY | 4 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 病理学PATHOLOGY | 4 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 血液学HEMATOLOGY | 4 区 |
| 小类 | 病理学PATHOLOGY | 4 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbase出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 1.03LetPub ·
- 影响因子（出版商公布） 2025
- 1出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 0.8出版商官网 ·
- CiteScore 2026-06
- 0.7LetPub ·
- SJR 2026-06
- 0.23LetPub ·
- SNIP 2026-06
- 0.39LetPub ·
- h-index
- 15LetPub ·
- h-index
- 25OpenAlex ·
- i10-index
- 83OpenAlex ·
- 两年平均被引
- 0.72OpenAlex ·
- 自引率
- 0%LetPub ·
- Gold OA 文章占比
- 25%LetPub ·
发文规模
- 年文章数
- 51LetPub ·
- 年下载量（出版商公布） 2025
- 283,700出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 732 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 59 | 20 | 5 |
| 2025 | 61 | 15 | 40 |
| 2024 | 45 | 44 | 74 |
| 2023 | 46 | 45 | 84 |
| 2022 | 49 | 48 | 86 |
| 2021 | 52 | 51 | 164 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
74 天投稿到接收中位数 · P25–P75 50 天 – 105 天
- 接收到上线
- 中位数 11 天（77 篇）
- 投稿到上线
- 中位数 88 天
- 样本
- 77 篇有投稿与接收日期的文章（窗口内共 72 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 投稿到首次决定
- 9 天出版商官网 ·
- 评审方式
- 单盲同行评审、双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,890 / EUR 2,990 / GBP 2,590 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点3 项，摘自作者指南
- 关键词
- ≥ 4 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 推荐审稿人
- 可选
接收的文章类型17 种，含篇幅限制
- case reportThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…正文 ≤ 1,500 词 · 图表 ≤ 4
- case reportsCase reports specially written-up single cases which present original observations, new insights into pathogenetic mechanisms and/or information based on novel …未说明篇幅
- commentaryThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…未说明篇幅
- commentsComments can portray your view on a topical or controversial subject in the field, as well as anything of likely interest to the readers.未说明篇幅
- correspondenceThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…未说明篇幅
- editorialSingle-blind peer review This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review proce…未说明篇幅
- imagesOne to Two figures, which may be in the form of panels and include insets, should demonstrate a very good example of an unusual finding about which hematopathol…未说明篇幅
- letterThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…正文 ≤ 1,000 词
- letters (correspondence)Letters may include commentaries about previous papers in the Journal of Hematopathology, on other matters of interest, reports on single cases, or negative fin…未说明篇幅
- meta-analysisThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…未说明篇幅
- original articleThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…正文 ≤ 3,500 词 · 参考文献 ≤ 50
- original articlesOriginal articles should not exceed 3,500 words (not including the abstract, references and legends).未说明篇幅
- perspectiveThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…未说明篇幅
- reportsReports on meetings, symposia and conferences that deal with hematopathology should include both a statement of the purpose of the meeting and a summary of the …未说明篇幅
- reviewThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…未说明篇幅
- review articleThe following types of articles will be considered for publication: Original articles Original articles should not exceed 3,500 words (not including the abstrac…正文 ≤ 4,500 词 · 图表 ≤ 5 · 参考文献 ≤ 60
- review articlesReview articles for the Journal of Hematopathology should comprise no more than 4,500 words and 60 references.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、试验注册 / 报告规范
- AI 使用 Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
原文 ↗出版商官网 ·- 数据可用性 Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
原文 ↗出版商官网 ·- 出版伦理 Instructions for Complying with Ethical Standards
Please include a section called “Compliance with Ethical Standards” within your manuscript. Please always include each type of statement as well as the exact statement order and wording as described below for the five disclosure statements. Please always add all five statements, even if one or more are not applicable. 1. Funding (must be included): “This study was funded by X (grant number X)” In …
原文 ↗出版商官网 ·- 许可与版权 Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
ORCID required for corresponding author 模型摘要
To find out more about publishing your work Open Access in Journal of Hematopathology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审 Single-blind peer review
Single-blind peer review 模型摘要
This journal follows a single-blind reviewing procedure. This journal also publishes special/guest-edited issues. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if a guest editor authors an article in their issue/collection, they will not handle the peer review process. Submitted manuscripts will generally be reviewed by t…
原文 ↗出版商官网 ·- 查重
Plagiarism screening via iThenticate 模型摘要
All manuscripts are evaluated via iThenticate for signs of any potential plagiarism.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer Berlin Heidelberg
- 出版国家或地区
- NETHERLANDS
- 出版语言
- English
- 出版周期
- 4 issues per year
- 创刊年份
- 2008
- ISSN
- 1868-9256
- 电子版 ISSN
- 1865-5785
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗出版商官网
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Journal of Hematopathology 的常见问题
Journal of Hematopathology 是中科院几区期刊？
2025 年升级版分区表中，Journal of Hematopathology 为医学 4区，小类 血液学 / 病理学 4 区。2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Journal of Hematopathology 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 1.03，CiteScore 为 0.7，h-index 为 25。
Journal of Hematopathology 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）77 篇已发表文章登记的日期，投稿到接收的中位数为 74 天（四分位 50–105 天）。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Journal of Hematopathology 的投稿格式要求是什么？
据期刊作者指南：关键词：≥ 4 个；参考文献格式：顺序编码制（按引用顺序编号）；推荐审稿人：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Journal of Hematopathology 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 41 位编委中，没有中国大陆学者；人数最多的国家是 美国（23 位）、德国（5 位）、荷兰（2 位）。统计按编委会页面列出的机构国家计，仅供参考。
Journal of Hematopathology 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Journal of Hematopathology 被 SCIE、Scopus 收录。期刊官网自述还被 MEDLINE、Embase 收录，该清单未与各数据库逐一核对。
Journal of Hematopathology 是开放获取期刊吗？版面费多少？
Journal of Hematopathology 为混合开放获取。选择开放获取发表时APC 约 3,890 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-25 归档）。最近更新：。